Trial Profile
Phase II study to evaluate pharmacodynamics, pharmacokinetics and safety after cyclic dose or continuous dose of FSN-013 for 3 cycles in Japanese healthy adult female subjects
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Drospirenone/estetrol (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Fuji Pharmaceutical
- 05 Sep 2018 Status changed from not yet recruiting to recruiting.
- 25 Jul 2018 New trial record